Compumedics Balance Sheet Health
Financial Health criteria checks 4/6
Compumedics has a total shareholder equity of A$18.2M and total debt of A$7.0M, which brings its debt-to-equity ratio to 38.3%. Its total assets and total liabilities are A$40.4M and A$22.1M respectively.
Key information
38.3%
Debt to equity ratio
AU$6.98m
Debt
Interest coverage ratio | n/a |
Cash | AU$1.89m |
Equity | AU$18.21m |
Total liabilities | AU$22.15m |
Total assets | AU$40.36m |
Recent financial health updates
We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt
Nov 03Is Compumedics (ASX:CMP) A Risky Investment?
May 27Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly
Oct 14Is Compumedics (ASX:CMP) Using Debt Sensibly?
May 02Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden
Jun 10These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively
Feb 25Recent updates
This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate
Oct 24Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce
Jun 17Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)
Mar 07We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt
Nov 03Is Compumedics (ASX:CMP) A Risky Investment?
May 27Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company
Jan 25Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year
Oct 19Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly
Oct 14Is Compumedics (ASX:CMP) Using Debt Sensibly?
May 02Compumedics (ASX:CMP) May Have Issues Allocating Its Capital
Dec 08Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends
Aug 09Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden
Jun 10Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)
May 06These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively
Feb 25How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?
Dec 01Financial Position Analysis
Short Term Liabilities: CMP's short term assets (A$26.2M) exceed its short term liabilities (A$21.3M).
Long Term Liabilities: CMP's short term assets (A$26.2M) exceed its long term liabilities (A$896.0K).
Debt to Equity History and Analysis
Debt Level: CMP's net debt to equity ratio (27.9%) is considered satisfactory.
Reducing Debt: CMP's debt to equity ratio has increased from 5.7% to 38.3% over the past 5 years.
Debt Coverage: CMP's debt is well covered by operating cash flow (28.7%).
Interest Coverage: Insufficient data to determine if CMP's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 07:49 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Compumedics Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ian Martin | New Street Research LLP |
Paul Jensz | PAC Partners Securities Pty. Ltd. |
Stephen Scott | Taylor Collison Limited |